acute lymphoblastic leukemia (all)

Showing 1 - 25 of 38

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myelogenous Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Chronic Myelogenous Leukemia (CML) Trial in United States

Recruiting
  • Acute Myelogenous Leukemia (AML)
  • +5 more
  • Conditioning Chemotherapy
  • Cord blood graft
  • Basking Ridge, New Jersey
  • +6 more
May 22, 2023

Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Neuroblastoma Trial in Worldwide (Idasanutlin, Venetoclax,

Recruiting
  • Acute Myeloid Leukemia (AML)
  • +3 more
  • Phoenix, Arizona
  • +19 more
Jan 18, 2023

Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL) Trial in Guediawaye GOL SUD (Pyronaridine Tetraphosphate)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Acute Lymphoblastic Leukemia (ALL)
  • Pyronaridine Tetraphosphate
  • Guediawaye GOL SUD, Dakar, Senegal
    Dalal Jamm Hospital
Nov 23, 2022

Acute Lymphoblastic Leukemia (ALL) Trial in Worldwide (Carfilzomib, Dexamethasone, Mitoxantrone)

Recruiting
  • Acute Lymphoblastic Leukemia (ALL)
  • Orange, California
  • +86 more
Nov 14, 2022

Acute Lymphoblastic Leukemia (ALL) Trial (Nilotinib)

No longer available
  • Acute Lymphoblastic Leukemia (ALL)
  • (no location specified)
Aug 5, 2022

Acute Lymphoblastic Leukemia (ALL) Trial in New Brunswick, Toronto (Bright Ideas - CIN Training)

Recruiting
  • Acute Lymphoblastic Leukemia (ALL)
  • Bright Ideas - CIN Training
  • New Brunswick, New Jersey
  • +1 more
Jul 30, 2022

CAR T Cells Real World Evidence Study Based on French Hospital

Completed
  • Diffuse Large B-Cell Lymphoma (DLBCL)
  • Acute Lymphoblastic Leukemia (ALL)
  • KYMRIAH
  • YESCARTA
  • East Hanover, New Jersey
    Novartis Investigative Site
Jun 29, 2022

Acute Lymphoblastic Leukemia (ALL) Trial in Baltimore, Houston, Seattle (Allopurinol)

Completed
  • Acute Lymphoblastic Leukemia (ALL)
  • Baltimore, Maryland
  • +2 more
Jun 17, 2022

Bio-CAR-T BS Study

Recruiting
  • Diffuse Large B Cell Lymphoma (DLBCL)
  • +2 more
    • Brescia, Italy
      ASST Spedali Civili di Brescia
    May 5, 2022

    Acute Lymphoblastic Leukemia (ALL), Non Hodgkin Lymphoma (NHL) Trial in Zhengzhou, Hangzhou (CD19-UCART)

    Recruiting
    • Acute Lymphoblastic Leukemia (ALL)
    • Non Hodgkin Lymphoma (NHL)
    • CD19-UCART
    • Zhengzhou, Henan, China
    • +1 more
    Apr 2, 2022

    Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma, Acute Myeloid Leukemia (AML) Trial (Venetoclax)

    Available
    • Chronic Lymphocytic Leukemia (CLL)
    • +6 more
    • (no location specified)
    Mar 28, 2022

    Acute Lymphoblastic Leukemia (ALL), Lymphoblastic Lymphoma Trial in Australia, United States (Navitoclax, Chemotherapy,

    Completed
    • Acute Lymphoblastic Leukemia (ALL)
    • Lymphoblastic Lymphoma
    • Duarte, California
    • +14 more
    Oct 7, 2021

    Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), MDS (MDS) Trial in Memphis (drug, biological, device)

    Recruiting
    • Acute Lymphoblastic Leukemia (ALL)
    • +7 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Oct 8, 2021

    Acute Lymphoblastic Leukemia (ALL) Trial in United States (Vincristine Sulfate Liposomes Injection (VSLI), Vincristine Sulfate

    Terminated
    • Acute Lymphoblastic Leukemia (ALL)
    • Vincristine Sulfate Liposomes Injection (VSLI)
    • Vincristine Sulfate Injection (VSI)
    • La Jolla, California
    • +14 more
    Sep 6, 2021

    Myeloid Leukemia, Chronic, Acute Myelogenous Leukemia, MDS (MDS) Trial in Palo Alto (Conventional T cells (Tcon) and Regulatory

    Recruiting
    • Myeloid Leukemia, Chronic
    • +8 more
    • Conventional T cells (Tcon) and Regulatory T cells (Treg)
    • Palo Alto, California
      Stanford University School of Medicine Palo Alto, California, Un
    Aug 18, 2021

    Acute Lymphoblastic Leukemia (ALL) Trial in Worldwide (Marqibo® (vincristine sulfate liposomes injection))

    Completed
    • Acute Lymphoblastic Leukemia (ALL)
    • Marqibo® (vincristine sulfate liposomes injection)
    • Los Angeles, California
    • +32 more
    Feb 8, 2021

    Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML) Trial in Worldwide (NiCord®

    Active, not recruiting
    • Hematological Malignancies
    • +6 more
    • NiCord® (omidubicel)
    • Cord Blood Unit
    • Los Angeles, California
    • +51 more
    Jan 7, 2021

    Acute Lymphoblastic Leukemia (ALL) Trial in Worldwide (Bortezomib)

    Recruiting
    • Acute Lymphoblastic Leukemia (ALL)
    • Clayton, Victoria, Australia
    • +14 more
    Aug 14, 2020

    Acute Lymphoblastic Leukemia (ALL) Trial in Rennes (Impact of CD9 expression level on motility assays, Post-transcriptional

    Completed
    • Acute Lymphoblastic Leukemia (ALL)
    • Impact of CD9 expression level on motility assays
    • Post-transcriptional regulation of CD9
    • Rennes, France
      Rennes University Hospital
    Aug 11, 2020

    Chronic Myeloid Leukemia (CML), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in New York (CliniMACS

    Recruiting
    • Chronic Myeloid Leukemia (CML)
    • +5 more
    • CliniMACS CD34+ Reagent System
    • +8 more
    • New York, New York
      Columbia University Medical Center
    Jun 17, 2020

    Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Myelodysplastic Syndrome (MDS) Trial in United States

    Completed
    • Acute Myeloid Leukemia (AML)
    • +3 more
    • Phoenix, Arizona
    • +5 more
    Mar 25, 2020

    Genetic Study of Familial Acute Lymphoblastic Leukemia

    Completed
    • Acute Lymphoblastic Leukemia (ALL)
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      Dec 9, 2019

      Non-interventional, Long-term Follow-up of Subjects Who

      Unknown status
      • Acute Myelogenous Leukemia (AML)
      • +3 more
      • non intervational
      • Haifa, Israel
        Rambam Medical Center
      Nov 24, 2019